HDB (HDB) Stock Price & Analysis
HDB (HDB) rose 0.43% to USD 23.23 as of July 25, 2026 at 02:24 UTC, according to Nexqual real-time market data.
HDB last closed at USD 23.13; the session ranged USD 23.23–23.65 on volume of 9,076,197 shares. Market capitalization is $119.29B, with a 52-week range of USD 22.66–39.07 (NYQ). Source: Nexqual, July 25, 2026 at 02:24 UTC.
Key Statistics (as of July 25, 2026 at 02:24 UTC)
| Price | USD 23.23 |
|---|---|
| Change | ▲ 0.43% (up) |
| Previous Close | USD 23.13 |
| Open | USD 23.43 |
| Day Range | USD 23.23 – 23.65 |
| 52-Week Range | USD 22.66 – 39.07 |
| Volume | 9,076,197 shares |
| Market Cap | $119.29B |
| Exchange | NYQ |
Technical Analysis (HDB)
Nexqual's technical model rates HDB "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:24 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 36.58 (neutral) |
| vs SMA50 | Below (USD 24.78) |
| MACD | -0.42 (negative) |
Analyst Ratings (HDB)
Wall Street analysts rate HDB "Strong Buy" based on 4 analysts, with a mean price target of USD 33.95 (range USD 30.8–36), per Nexqual as of July 25, 2026 at 02:24 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 33.95 |
| High Target | USD 36 |
| Low Target | USD 30.8 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (HDB)
| Next Earnings Date | 2026-10-17 |
|---|---|
| EPS Estimate | USD 0.39 |
| Revenue Estimate | $481.30B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.38 vs est 0.39 ▼ miss |
| 2026-03-31 | USD 0.4 vs est 0.39 ▲ beat |
| 2025-12-31 | USD 0.4 vs est 0.39 ▲ beat |
| 2025-09-30 | USD 0.41 vs est 0.36 ▲ beat |
Source: Nexqual, July 25, 2026 at 02:24 UTC.
Financials & Fundamentals (HDB)
| Total Revenue | $2.95T |
|---|---|
| Revenue Growth (YoY) | +16.60% |
| Gross Margin | +0.00% |
| Operating Margin | +33.29% |
| Profit Margin | +26.79% |
| ROE | +13.84% |
| Total Cash | $2.38T |
| Total Debt | $5.66T |
Source: Nexqual, July 25, 2026 at 02:24 UTC.
Financial Health Score (HDB)
Nexqual rates HDB's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 02:24 UTC.
| Growth | Critical — Revenue -33% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Gross margin 0% |
| Balance Sheet | Mixed — $2.38T cash vs $5.66T debt |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — ROE 14%, ROA 1.8% |
Ownership (HDB)
| Insider Ownership | +0.03% |
|---|---|
| Institutional Ownership | +13.59% |
| Shares Outstanding | 5.14B |
| Float | 25.56B |
| Short % of Float | +0.37% |
Source: Nexqual, July 25, 2026 at 02:24 UTC.
Leadership (HDB)
HDB is led by Sashidhar Jagdishan (age 60), MD, CEO & Director, per Nexqual as of July 25, 2026 at 02:24 UTC.
| MD, CEO & Director | Sashidhar Jagdishan (age 60) |
|---|---|
| Deputy MD & Director | Kaizad Maneck Bharucha (age 60) |
| Executive Whole-Time Director | Vedanthachari Srinivasa Rangan (age 65) |
| Chief Financial Officer | Srinivasan Vaidyanathan (age 61) |
| Chief Marketing Officer & Group Head | Ravi Santhanam (age 54) |
Major Backers & Investors (HDB)
Notable institutional backers of HDB include Royal Bank of Canada, GQG Partners LLC, Morgan Stanley, according to Nexqual as of July 25, 2026 at 02:24 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Royal Bank of Canada | 0.83% |
| GQG Partners LLC | 0.66% |
| Morgan Stanley | 0.6% |
| Schroder Investment Management Group | 0.44% |
| Harding Loevner LP | 0.38% |
| JPMorgan | 0.36% |
| Principal Financial Group, Inc. | 0.35% |
| FIL LTD | 0.33% |
Source: Nexqual, July 25, 2026 at 02:24 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IBN | ICICI Bank Limited | USD 29.51 | ▲ 0.2% |
| RDY | Dr. Reddy's Laboratories Ltd | USD 11.79 | ▲ 3.6% |
| WIT | Wipro Limited | USD 1.87 | ▲ 3.31% |
| INFY | Infosys Limited | USD 11.11 | ▲ 1.65% |
| SAY | Saratoga Investment Corp 8.125% | USD 25.3 | ▲ 0.08% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:24 UTC. This page is informational and not investment advice.